Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.maxhealthcare.in | |
Market Cap | 42,702.20 Cr. | |
Enterprise Value(EV) | 42,512.35 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 9.72 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 45.25 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 46.72 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 71.27 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 6.17 | Calculated using Price: 439.85 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 97.08 Cr. | 970,835,453 Shares |
FaceValue | 10 | |
Company Profile | ||
The company offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda. It provides services in the areas of cardiology, orthopedics and joint replacement, cancer, neurosciences, pediatrics, obstetrics and gynecology, aesthetics and reconstructive plastic surgery, internal medicine, eye and dental care, endocrinology, diabetes, obesity, ENT, metal health and behavioral sciences, physiotherapy and rehabilitation, and nuclear medicine, as well as minimal access, metabolic, and bariatric surgery. |
1 Day |
|
-3.36% |
1 Week |
|
-0.81% |
1 Month |
|
+0.21% |
3 Month |
|
+2.23% |
6 Month |
|
+19.10% |
1 Year |
|
+18.96% |
2 Year |
|
+171.43% |
5 Year |
|
|
10 Year |
|
8 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -5.64 | -2.29 | 1.35 | -2.44 | -0.02 | 0.73 | -2.80 | 10.19 | |
Return on Capital Employed (%) | 2.11 | 3.05 | 5.20 | 3.46 | 5.32 | 3.57 | 2.22 | 12.38 | |
Return on Assets (%) | -2.71 | -1.01 | 0.51 | -0.89 | -0.01 | 0.35 | -1.83 | 6.82 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 963 | 2,553 | 5,639 | 6,282 | 6,918 | |
Non Curr. Liab. | 1,251 | 411 | 2,128 | 2,149 | 1,775 | |
Curr. Liab. | 1,140 | 1,010 | 777 | 757 | 811 | |
Minority Int. | ||||||
Equity & Liab. | 3,355 | 3,974 | 8,543 | 9,189 | 9,504 | |
Non Curr. Assets | 2,907 | 1,058 | 7,419 | 8,189 | 8,171 | |
Curr. Assets | 447 | 2,915 | 1,124 | 1,000 | 1,332 | |
Misc. Exp. not W/O | ||||||
Total Assets | 3,355 | 3,974 | 8,543 | 9,189 | 9,504 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 1,691 | 1,059 | 2,508 | 3,931 | 4,116 | |
Other Income | 67 | 48 | 135 | 137 | 131 | |
Total Income | 1,758 | 1,107 | 2,643 | 4,068 | 4,247 | |
Total Expenditure | -1,546 | -965 | -2,124 | -2,998 | -3,077 | |
PBIDT | 212 | 142 | 519 | 1,070 | 1,170 | |
Interest | -101 | -83 | -179 | -101 | -91 | |
Depreciation | -103 | -46 | -174 | -221 | -228 | |
Taxation | -9 | 0 | -46 | -134 | 95 | |
Exceptional Items | -234 | -9 | -1 | |||
PAT | 0 | 13 | -115 | 605 | 944 | |
Minority Interest | -3 | |||||
Share Associate | 46 | -23 | ||||
Other Related Items | ||||||
Consolidated Net Profit | -3 | 59 | -138 | 605 | 944 | |
Adjusted EPS | 0 | 1 | -1 | 6 | 10 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 89 | 77 | 118 | 748 | |
Cash Fr. Inv. | -17 | -2,641 | -73 | -772 | |
Cash Fr. Finan. | -74 | 2,353 | 191 | -294 | |
Net Change | -2 | -210 | 236 | -317 | |
Cash & Cash Eqvt | 8 | 111 | 627 | 309 |
Mon, 30 Jan 2023
Update on board meeting Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve Proposal for Issue of Non-Convertible Debentures |
Fri, 27 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Earnings Call on financial results of Max Healthcare Institute Limited for the quarter and nine months ended December 31 2022 for investors and analysts is being organized on Friday February 03 2023 at 11:00 am (IST). |
Tue, 24 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting Of Max Healthcare Institute Limited Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve Pursuant to regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday February 02 2023 inter-alia to consider and approve Unaudited Standalone and Consolidate Financial Results of the Company for the quarter and nine months ended December 31 2022. |
Mon, 30 Jan 2023 |
|
|
|
|
|